Trial intelligence / Profile preview

Glucocorticoid Dose Regimens in ABPA

NCT00974766Phase 3Completed

Sponsor
Post Graduate Institute of Medical Education and Research
Start
Apr 2009
Primary completion
Mar 2011
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of prednisolone in allergic bronchopulmonary aspergillosis (ABPA), sponsored by Post Graduate Institute of Medical Education and Research. Started Apr 2009; status: completed.

02

Drugs

prednisolone
03

Conditions

allergic bronchopulmonary aspergillosis (ABPA)

Beyond the preview

Go deeper on NCT00974766.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00974766.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call